Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Fentanyl overdoses can happen in minutes, and the usual tools respond after the damage is already underway. A proposed ...

Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested ...

A research team at Florida State University's Institute of Molecular Biophysics and Department of Chemistry and Biochemistry ...

"With ALMA, we can now see the atmosphere of a dying star with a level of clarity in a similar way to what we do for the sun.

Researchers from Montreal Clinical Research Institute (IRCM) have identified a new molecule, naturally produced in the body, could be used to treat inflammatory bowel disease (IBD). In a study ...

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

A programmable semiconductor changes its electronic properties under UV light and reverts under a different wavelength, ...

OTR Therapeutics and Zealand Pharma collaborate to develop novel metabolic disease treatments, with a potential deal value of ...

Neurenati Therapeutics, a biotech company focused on the development of therapies for rare diseases, is pleased to appoint ...

They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.

One of the most intriguing parts of the morning shed - and one that seems to deliver the most immediate results - is the face ...